Baillie Gifford - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 160 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$465
-39.6%
3080.0%0.00%
Q4 2022$770
-23.0%
3080.0%0.00%
Q3 2022$1,0000.0%3080.0%0.00%
Q2 2022$1,000
-50.0%
3080.0%0.00%
Q1 2022$2,000
-33.3%
3080.0%0.00%
Q4 2021$3,0000.0%3080.0%0.00%
Q3 2021$3,000
-40.0%
3080.0%0.00%
Q2 2021$5,0000.0%3080.0%0.00%
Q1 2021$5,000
-28.6%
308
-5.5%
0.00%
Q4 2020$7,0003260.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders